Gilfoyle Management »

Crispr Therapeutics shares owned by Gilfoyle Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Gilfoyle Management from 13F filings

Historical chart of Gilfoyle Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Gilfoyle Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Gilfoyle Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $6.4k 150 42.51
2023-06-30 $4.8k 100 48.42